GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

By Blake Brittain (Reuters) -GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies’ blockbuster COVID-19 vaccines. GSK said in the lawsuit that Pfizer and BioNTech’s Comirnaty vaccines violate the company’s patent rights in mRNA-vaccine innovations developed “more than…

Read More

Cisco says hackers subverted its security devices to spy on governments

By Raphael Satter WASHINGTON (Reuters) – Technology firm Cisco Systems said that hackers have subverted some of its digital security devices to break in to government networks globally. In a blog post published on Wednesday, the company said its Adaptive Security Appliances – pieces of equipment that roll several different digital defense functions into one…

Read More

Visa results beat estimates on resilient consumer spending

By Manya Saini and Pritam Biswas (Reuters) -Visa’s second-quarter results sailed past Wall Street estimates on Tuesday, as consumers shrugged off worries of a slowing economy to swipe cards on everything from travel to dining out, sending its shares up 2.7% after the bell. U.S. consumer spending has remained remarkably resilient despite higher-for-longer interest rates,…

Read More

Coca-Cola signs $1.1 billion deal to use Microsoft cloud, AI services

By Stephen Nellis (Reuters) – Microsoft said on Tuesday that Coca-Cola had signed a $1.1 billion five-year deal to use its cloud computing and artificial intelligence services. Under the agreement, Microsoft and Coca-Cola will “jointly experiment” with Azure OpenAI. That service uses technology from Microsoft-backed startup and ChatGPT creator OpenAI to let customers build chatbots…

Read More